• slider1

    Home1

  • slider2

    Slide2

  • slider3

    Slide3

  • slider4

    Slide 4

FloSure Technologies is a global technology and medical
 equipment/device company dedicated to bringing new and
 innovative medical technologies to the market.

Specializing in the development of respiratory and wound care medical devices, we identify new
challenges and unmet needs in current systems, then, we fund, research, develop and engineer the next
generation of medical devices to meet those challenges. Focusing in the areas of respiratory and
wound care, it is our mission to not only reimagine the future of medical devices by bringing the best
minds and resources available to engineer new solutions, but to also deliver these products globally.

FloSure Technologies
will be exhibiting at:

ATS Annual Congress 
May 19-24, 2017 Washington DC


APIC 2017
June 14-16, Portland Oregon


ERS Annual Conference
Sept 9-13, 2017 Milan, Italy


AARC Annual Congress
Oct 4-7, 2017 Indianapolis, Indiana


CHEST Annual Meeting
Oct 28 -Nov 1, Toronto, Canada

New &
Noteworthy

During AARC 2016 in San Antonio TX, Dr. Jerry Gentile presented the results of Randomized Controlled Trial (RCT) Study comparing the efficacy of the SIMEX Automated Intermittent Subglottic Aspiration System in the Prevention of VAP and VAE in Long Term, Tracheostomized, Mechanically-ventilated Patients. This was the first RCT conducted in Long Term Care arena in the US.
Click here to view the presentation »

The results of the RCT was presented at the 2016 CHEST Congress, Los Angeles CA.
Please click here to view »

A novel technique called “Gentile Green Dye Method” to detect dysplasia was presented at the 2016 CHEST Congress, Los Angeles CA.
Please click here to view »

Subscribe to our
Mailing List

* indicates required




"Using syringe or other conventional suction sources for SSD proved impractical and ineffective in our institution. An 8-month trial of 10 patients using the SIMEX automated subglottic aspiration system resulted in significant increases in volumes of secretions collected, significant decreases in maceration and soiling, and there were no incidents of VAE or VAC."

 

Jerry Gentile, BSRT, BSHA, MBA, EdD(c), RT, RRT
Partner, Sevara Health, LLC
Director of Respiratory Care Services
Eastchester Rehabilitation & Healthcare Center, Bronx, New York